Document:

Unassociated Document

    EMPLOYMENT
      AGREEMENT

     

    EMPLOYMENT
      AGREEMENT (the “Agreement”), entered into on September 8, 2006, by and between
      iCAD, Inc., a Delaware corporation (the “Company”), and Darlene M. Deptula-Hicks
      (the “Executive”).

     

    WITNESSETH:

     

    WHEREAS,
      the Company desires to employ the Executive as its Executive Vice President
      of
      Finance and Chief Financial Officer upon the terms and subject to the conditions
      set forth in this Agreement; and

     

    WHEREAS,
      the Executive is willing to accept such employment upon such terms;

     

    NOW,
      THEREFORE, in consideration of the covenants and agreements hereinafter set
      forth and other good and valuable consideration, the receipt and sufficiency
      of
      which are hereby acknowledged, the parties hereto agree as follows:

     

    1. EMPLOYMENT
      AND DUTIES

     

    1.1. Term
      of Employment.
      The
      Executive’s employment under this Agreement shall commence on September
 11, 2006 (the “Start Date”) and shall continue until December 31,
      2008, (such period being herein referred to as the “Initial Term,” and the
      period from the Start Date through December 31, 2006 and any year
      thereafter ending on December 31 shall be referred to as an “Employment
      Year”). After the Initial Term and on the last day of any Employment Year
      thereafter, this Agreement shall be automatically renewed for successive one
      year periods (each such period being referred to as a “Renewal Term”), unless,
      more than ninety (90) days prior to the expiration of the Initial Term or any
      Renewal Term, either the Executive or the Company gives written notice that
      employment will not be renewed, whereupon the term of the Executive’s employment
      (the “Term”) shall terminate upon the expiration of the Initial Term or the then
      current Renewal Term, unless sooner terminated pursuant to Section 5
      hereof.

     

    1.2. General.

     

    1.2.1. During
      the Term, the Executive shall have the title of Executive Vice President of
      Finance and Chief Financial Officer of the Company and shall have such duties
      as
      may be from time to time delegated to her by the Chief Executive Officer and
      the
      Board of Directors of the Company (the “Board”). The Executive shall faithfully
      and diligently discharge her duties hereunder and use her best efforts to
      implement the policies established by the Board. The Executive's
      responsibilities shall include, among other things, to render executive, policy,
      operations and other management services to the Company of the type customarily
      provided by persons situated in similar executive and management
      capacities.

     

    The
      Executive shall devote all of her business time, attention, knowledge and skills
      faithfully, diligently and to the best of her ability, in furtherance of the
      business and activities of the Company, provided,
      however,
      that
      nothing in this Agreement shall preclude the Executive from devoting reasonable
      periods of time required for serving as a director and member of a committee
      of
      the board of directors of any of the organizations or corporations of which
      the
      Executive currently serves or may serve in the future so long as (i) such
      activities involve no conflict of interest with the interests of the Company,
      (ii) the Executive notifies the Board of Directors of the Company of any new
      appointment and the Board does not object to such appointment, and (iii) such
      activities do not materially interfere with the performance of the Executive’s
      duties and responsibilities under this Agreement. 

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

     

    1.3. Reimbursement
      of Expenses.
      

     

    (a) The
      Company shall pay to the Executive the reasonable expenses incurred by her
      in
      the performance of her duties hereunder, including, without limitation, those
      incurred in connection with the use of an automobile, business related travel
      or
      entertainment, or, if such expenses are paid directly by the Executive, the
      Company shall promptly reimburse her for such payments, provided that the
      Executive properly accounts for such expenses in accordance with the Company's
      policy.

     

    (b) The
      Company shall pay to the Executive an automobile expense allowance in the amount
      of $1,000 per month. The Executive shall pay all the expenses of maintaining,
      insuring and operating such automobile.

     

    1.4
      Consideration.
      In
      consideration for the Executive’s execution of this Agreement, the Company
      agrees that the Executive shall become employed by the Company as set forth
      in
      this Agreement, the Executive shall be permitted access to the Company’s
      confidential information and shall be eligible to receive post-Term severance
      payments (Sections 5.4.2 and 5.4.3) as set forth in this Agreement (subject
      to
      her compliance with Sections 7 and 8 of this Agreement). The Executive
      understands, acknowledges and agrees that the Executive would not receive the
      consideration specified in this Section 1.4, except for the Executive’s
      execution of this Agreement and the fulfillment of the promises contained
      herein. 

     

    2. COMPENSATION

     

    2.1. Base
      Salary.
      During
      the Term, the Executive shall be entitled to receive a base salary (“Base
      Salary”) at a rate of two hundred five thousand dollars ($205,000.00) per annum
      during the Term, which Base Salary shall be payable in arrears in equal
      installments not less frequently than on a bi-monthly basis in accordance with
      the payroll practices of the Company, with such increases as may be determined
      by the Board from time to time.

     

    2.2. Signing
      Bonus.
      In
      addition to the Base Salary, the Company shall pay to the Executive a signing
      bonus of $20,000, which bonus shall be paid with the Company’s first payroll
      following the commencement of the Term.

     

    2.3. Incentive
      Bonus.
      The
      Executive shall be eligible to receive, for each Employment Year during the
      Term
      (other than the year ending December 31, 2006), an annual incentive bonus in
      each calendar year ending December 31 of up to an amount equal to $82,000
      (the “Incentive Bonus”) if the Company achieves goals and objectives mutually
      agreed upon in writing by the Board of Directors and the Executive for each
      Employment Year; provided, however, that the Incentive Bonus for the year ending
      December 31, 2006 shall be such amount as determined by the Board of
      Directors but in any event not be less than $27,000. The Incentive Bonus shall
      be paid in a single lump sum no later than 15 calendar days following the date
      on which the Company files with the Securities and Exchange Commission (the
      “SEC”) its Annual Report on Form 10-K (or Form 10-KSB) which includes audited
      financial statements for such Employment Year audited by an independent
      registered public accounting firm.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    

     

    2.4. Stock
      Options.

     

    (a)
      In
      addition to the Base Salary and Incentive Bonuses, if any, the Executive shall
      receive, as incentive compensation, options (“Options”) to purchase up to an
      aggregate of 275,000 shares (the “Shares”) of common stock of the Company,
      pursuant to and upon the terms and conditions set forth in the form of Option
      Agreement (the “Option Agreement”) attached as Exhibit A hereto. The Options
      shall vest and be exercisable as to 55,000 of the Shares immediately, 55,000
      of
      the Shares on March 31, 2007, 55,000 of the Shares on September 11, 2007, 55,000
      of the Shares on September 11, 2008 and 55,000 of the Shares on September 11,
      2009, subject to earlier vesting as set forth in this Section 2.4 and Section
      5.4.4(ii), and thereafter until September 11, 2011, subject to earlier
      termination as provided in the Option Agreement, at an exercise price per share
      equal to the
      last
      sales price for the Company's common stock on the date hereof.
      Vesting
      of the Options shall accelerate as to the 55,000 Shares to which the Option
      becomes exercisable at the latest date (to the extent any such Shares remain
      unvested at the time), upon the closing sale price of the Company’s common stock
      for a period of twenty (20) consecutive trading days exceeding
      (i) 200% of the exercise price of the per share of the Options;
      (ii) 300% of the exercise price per share of the Options or (iv) 400% of
      the exercise price per share of the Options.

     

    (b)
      The
      Executive agrees not to sell, contract to sell, sell or grant any option, right,
      warrant or option to purchase, purchase any option or contract to sell, pledge,
      hypothecate or otherwise transfer or dispose of the Shares prior to September
      11, 2007.

     

    2.5. Additional
      Compensation.
      In
      addition to the Base Salary, Additional Salary and the Incentive Bonuses, if
      any, and the Options, the Executive shall be entitled to receive such other
      cash
      bonuses and such other compensation in the form of stock, stock options or
      other
      property or rights as may from time to time be awarded her by the Board during
      or in respect of her employment hereunder.

     

    3. PLACE
      OF
      PERFORMANCE. In connection with her employment by the Company, the Executive
      shall be based at the Company’s principal executive offices in Nashua, New
      Hampshire, subject to the mutual agreement of the Executive and the Company
      to
      relocate her to another office of the Company. 

     

    4. EMPLOYEE
      BENEFITS

     

    4.1. Benefit
      Plans.
      The
      Executive shall, during the Term, be included to the extent eligible thereunder
      in all employee benefit plans, programs or arrangements of general application
      (including, without limitation, any plans, programs or arrangements providing
      for retirement benefits, options and other equity-based incentive compensation,
      profit sharing, bonuses, disability benefits, health and life insurance, or
      vacation and paid holidays) which shall be established by the Company or any
      affiliate of the Company, for, or made available to, their respective senior
      executives (“Benefits”). During the Term, the Benefits described in this Section
      4.1 may only be reduced as a result of a general reduction for senior
      executives.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    

     

    4.2. Vacation.
      The
      Executive shall be entitled to not less than four (4) weeks vacation at full
      pay
      for each year during the Term. Such vacation may be taken in the Executive’s
      discretion, and at such time or times as are not inconsistent with the
      reasonable business needs of the Company. 

     

    5. TERMINATION
      OF EMPLOYMENT

     

    5.1. General.
      The
      Executive’s employment under this Agreement may be terminated without any breach
      of this Agreement only on the following circumstances:

     

    5.1.1. Death.
      The
      Executive’s employment under this Agreement shall terminate upon her
      death.

     

    5.1.2. Disability.
      If, as
      a result of the Executive’s Disability (as defined below), the Executive shall
      have been absent from her duties under this Agreement for sixty (60) consecutive
      days, the Company may terminate the Executive’s employment upon fifteen (15)
      days prior written notice; provided that the Executive has not returned to
      full
      time performance of her duties during such fifteen (15)-day period. For purposes
      hereof, “Disability” shall mean that the Executive is unable to perform her
      normal and customary duties hereunder as a result of physical or mental
      incapacity, illness or disability.

     

    5.1.3. Good
      Reason.
      The
      Executive may terminate her employment under this Agreement for Good Reason
      at
      any time. For purposes of this Agreement, “Good Reason” shall mean:

     

    (i) The
      failure by the Company to comply with its material obligations and agreements
      contained in this Agreement;

     

    (ii) A
      material diminution of the executive responsibilities or title of the Executive
      with the Company without the consent of the Executive; or 

     

    (iii) A
      reduction by the Company in the Base Salary as in effect on the date hereof,
      or
      as the same may be increased from time to time, without the express written
      consent of the Executive,

     

    provided,
      however,
      that
      the Executive shall have provided the Company with written notice that such
      actions are occurring and the Company has been afforded a reasonable opportunity
      of at least thirty (30) days to cure the same.

    

    

    5.1.4. Cause.
      The
      Company may terminate the Executive’s employment under this Agreement for Cause.
      Termination for “Cause” shall mean termination of the Executive’s employment
      because of the occurrence of any of the following as determined by the
      Board:

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    

     

    (i) the
      failure or refusal by the Executive to substantially perform her obligations
      under this Agreement (other than any such failure resulting from the Executive’s
      incapacity due to physical or mental incapacity, illness or disease);
provided,
      however,
      that
      the Company shall have provided the Executive with written notice that such
      actions are occurring and the Executive has been afforded a reasonable
      opportunity of at least fifteen (15) days to cure same, or

     

    (ii) the
      indictment of the Executive for a felony or other crime involving moral
      turpitude or dishonesty; or

     

    (iii) a
      breach
      of Section 7 or Section 8 hereof or a breach of any representation contained
      in
      this Agreement by the Executive; or

     

    (iv) a
      breach
      of fiduciary duty involving personal profit; or

     

    (v) a
      material act of dishonesty in connection with her employment with the Company;
      or

     

    (vi) the
      Executive’s possession or use of illicit drugs, a prohibited substance or
      alcohol, to such extent that it impairs her ability to perform her duties and
      responsibilities; or

     

    (vii) the
      Executive having committed acts or omissions constituting gross negligence
      or
      willful misconduct (including theft, fraud, embezzlement, and securities law
      violations) which is injurious to the Company, monetarily, or otherwise. For
      purposes of this Section 5.1.4(vii), no act, or failure to act, on the part
      of
      the Executive shall be considered “gross negligence” or “willful” unless done,
“or” omitted to be done, by her in bad faith and without reasonable belief that
      her action or omission was in the best interest of the Company; or.

     

    (viii) the
      Executive having committed any violation of, or noncompliance with, any
      securities law, rule or regulation or stock exchange or Nasdaq Stock Market
      regulation rule relating to or affecting the Company, including without
      limitation,  the Executive’s failure or refusal to honestly provide a
      certificate in support of the chief executive officer’s and/or principal
      executive officer’s certification required under the Sarbanes-Oxley Act of 2002,
      including the rules and regulations promulgated thereunder (the “Sarbanes-Oxley
      Act”).

     

    5.2. Notice
      of Termination.
      Any
      termination of the Executive’s employment by the Company or by the Executive
      (other than termination by reason of the Executive’s death) shall be
      communicated by written Notice of Termination to the other party of this
      Agreement. For purposes of this Agreement, a “Notice of Termination” shall mean
      a notice which shall indicate the specific termination provision in this
      Agreement relied upon and shall set forth in reasonable detail the facts and
      circumstances claimed to provide a basis for termination of the Executive’s
      employment under the provision so indicated.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    

     

    5.3. Date
      of Termination.
      The
“Date of Termination” shall mean (a) if the Executive’s employment is
      terminated by her death, the date of her death, (b) if the Executive’s
      employment is terminated pursuant to subsection 5.1.2 above, fifteen (15) days
      after Notice of Termination is given (provided that the Executive shall not
      have
      returned to the performance of her duties on a full-time basis during such
      fifteen (15)-day period), (c) if the Executive’s employment is terminated
      pursuant to subsection 5.1.3 or 5.1.4 above, the date specified in the Notice
      of
      Termination after the expiration of any applicable cure periods, if any, and
      (d) if the Executive’s employment is terminated for any other reason, the
      date on which a Notice of Termination is given.

     

    5.4. Compensation
      Upon Termination.
      

     

    5.4.1. Termination
      for Cause.
      If the
      Executive’s employment shall be terminated for Cause, the Company shall pay the
      Executive her Base Salary through the Date of Termination, at the rate in effect
      at the time Notice of Termination is given, and all expenses and accrued
      Benefits arising prior to such termination which are payable to the Executive
      pursuant to this Agreement through the Date of Termination and the Company
      shall
      have no further obligation with respect to this Agreement. 

     

    5.4.2. Termination
      without Cause.
      Subject
      to the provisions of subsection 5.4.3 hereof, if, prior to the expiration of
      the
      Term, the Executive’s employment hereunder is terminated by the Company without
      Cause (other than a termination by reason of Disability), or by the Executive
      for Good Reason, the Company shall pay to the Executive all expenses and accrued
      Benefits arising prior to such termination which are payable to the Executive
      pursuant to this Agreement through the Date of Termination and the Company
      shall
      continue to pay the Executive her Base Salary as then in effect for the greater
      of (i) the remainder of the original Term or (ii) a period of one year
      (1) year from the Date of Termination (such period being referred to hereinafter
      as the “Severance Period”), payable in monthly installments and, shall pay a pro
      rata portion of the Incentive Bonus, if any, earned for the Employment Year
      through the Date of Termination in the discretion of the Board of Directors,
      at
      such time the Incentive Bonus, if any, would otherwise have been payable in
      accordance with Section 2.3 hereof. In addition, during the Severance Period,
      the Executive shall be entitled to continue to participate in all employee
      benefit plans that the Company provides (and continues to provide) generally
      to
      its senior executives. 

     

    5.4.3. Death
      During Severance Period.
      In the
      event of the Executive’s death during the Severance Period, payments of Base
      Salary under this Section 5.4 and payments under the Company’s employee benefit
      plan(s) shall continue to be made in accordance with their terms during the
      remainder of the Severance Period to the beneficiary designated in writing
      for
      such purpose by the Executive or, if no such beneficiary is specifically
      designated, to the Executive’s estate.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    

     

    5.4.4. Termination
      Following Change in Control.

     

    (i) Anything
      contained herein to the contrary notwithstanding, in the event the Executive’s
      employment hereunder is terminated within six (6) months following a Change
      in
      Control (as defined below) by the Company without Cause, or by the Executive
      for
      Good Reason, then
      the
      Company shall pay to the Executive in complete satisfaction of its obligations
      under this Agreement, as severance pay and as liquidated damages (because actual
      damages are difficult to ascertain), an amount equal to (i) (a)
her
      Base
      Salary as then in effect for the greater of (x) the remainder of the
      original Term or (y) a period of one (1) year from the Date of
      Termination plus (b) an amount equal to the Incentive Bonus which would
      otherwise been payable in accordance with Section 2.3 hereof for the
      Employment Year in which the Date of Termination occurs,
      in
      monthly installments commencing 30 days following the Date of Termination;
      or
      (ii) a lump sum cash payment equal to the present value of the payments
      otherwise due under clause (i); provided that if such severance payment,
      either alone or together with other payments or benefits, either cash or
      non-cash, that the Executive has the right to receive from the Company,
      including, but not limited to, accelerated vesting or payment of any deferred
      compensation, options, stock appreciation rights or any benefits payable to
      the
      Executive under any plan for the benefit of employees, which would constitute
      an
“excess parachute payment” (as defined in Section 280G of the Internal Revenue
      Code of 1986), then such severance payment or other benefit shall be reduced
      to
      the largest amount that will not result in receipt by the Executive of a
      parachute payment. The determination of the amount of the payment described
      in
      this subsection shall be made by the Company’s independent auditors at the sole
      expense of the Company. For purposes of clarification the value of any options
      described above will be determined by the Company’s independent auditors using a
      Black-Scholes valuation methodology.

     

    For
      purposes of this Agreement, a “Change in Control” shall be deemed to
      occur (i) when
      any “person” as defined in Section 3(a)(9) of the Securities Exchange Act of
      1934, as amended (the “Exchange Act”), and as used in Section 13(d) and 14(d)
      thereof, including a “group” as defined in Section 13(d) of the Exchange Act,
      but excluding the Executive, the Company or any subsidiary or any affiliate
      of
      the Company or any employee benefit plan sponsored or maintained by the Company
      or any subsidiary of the Company (including any trustee of such plan acting
      as
      trustee), becomes the “beneficial owner” (as defined in Rule 13(d)(3) under the
      Exchange Act) of securities of the Company representing 50% or more of the
      combined voting power of the Company’s then outstanding securities; or
      (ii) the occurrence of a transaction requiring stockholder approval for the
      acquisition of the Company by an entity other than the Company or a subsidiary
      or an affiliated company of the Company through purchase of assets, or by
      merger, or otherwise.

     

    (ii) If
      within
      six (6) months after the occurrence of a Change in Control, the Company shall
      terminate the Executive’s employment without Cause, or the Executive shall
      terminate her employment for Good Reason, then notwithstanding the vesting
      and
      exercisability schedule in any stock option agreement between the Company and
      the Executive, all unvested stock options granted by the Company to the
      Executive pursuant to such agreement shall immediately vest and become
      exercisable and shall remain exercisable for not less than 180 days
      thereafter.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    

     

    5.4.5. Termination
      upon Death or Disability.
      In the
      event of the termination of the Executive's employment by reason of death or
      Disability, the Company shall pay the Executive her Base Salary through the
      Date
      of Termination, at the rate then in effect, and all expenses or accrued Benefits
      arising prior to such termination which are payable to the Executive pursuant
      to
      this Agreement through the Date of Termination. In addition, the Executive
      and/or her beneficiaries shall be entitled to such other Benefits as shall
      be
      determined in accordance with the benefit plans maintained by the Company.
      

     

    6. INSURABILITY;
      RIGHT TO INSURE

     

    During
      the continuance of the Executive's employment hereunder, the Company shall
      have
      the right to maintain key man life insurance in its own name covering the
      Executive's life in such amount as shall be determined by the Company, for
      a
      term ending on the termination or expiration of this Agreement. The Executive
      shall aid in the procuring of such insurance by submitting to the required
      medical examinations, if any, and by filling out, executing and delivering
      such
      applications and other instrument in writing as may be reasonably required
      by an
      insurance company or companies to which application or applications for
      insurance may be made by or for the Company.

     

    7. CONFIDENTIALITY;
      NONCOMPETITION; NONSOLICITATION; NONDISPARAGEMENT 

     

    7.1. The
      Company and the Executive acknowledge that the services to be performed by
      the
      Executive under this Agreement are unique and extraordinary and, as a result
      of
      such employment, the Executive shall be in possession of confidential
      information relating to the business practices of the Company. The term
“confidential information” shall mean any and all information (oral and written)
      relating to the Company or any of its affiliates, or any of their respective
      activities, as well as any distributors, vendors, suppliers, customers or other
      third party of which the Executive shall possess in connection with her
      employment with the Company, other than such information which (i) can be shown
      by the Executive to be in the public domain (such information not being deemed
      to be in the public domain merely because it is embraced by more general
      information which is in the public domain) other than as the result of breach
      of
      the provisions of this Section 7.1 or (ii) the Executive is required to disclose
      under any applicable laws, regulations or directives of any government agency,
      tribunal or authority having jurisdiction in the matter or under subpoena or
      other process of law. The Executive shall not, during the Term and for a period
      of five (5) years thereafter, except as may be required in the course of the
      performance of her duties hereunder, directly or indirectly, use, communicate,
      disclose or disseminate to any person, firm or corporation any confidential
      information regarding the clients, customers or business practices of the
      Company acquired by the Executive, without the prior written consent of the
      Company; provided,
      however,
      that
      the Executive understands that Executive shall be prohibited from
      misappropriating any trade secret at any time during or after the Term.

     

    7.2. Upon
      the
      termination of the Executive’s employment for any reason whatsoever, all
      documents, records, notebooks, equipment, price lists, specifications, programs,
      customer and prospective customer lists and other materials which refer or
      relate to any aspect of the business of the Company which are in the possession
      of the Executive, including all copies thereof, shall be promptly returned
      to
      the Company.

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    

     

    7.3. The
      Executive hereby agrees that she shall not, during the Term and for a period
      of
      two years after the Date of Termination, directly or indirectly, within any
      county (or adjacent county) in any State within the United States or territory
      outside of the United States in which the Company is engaged in business during
      the Term, engage, have an interest in or render any services to any business
      (whether as owner, manager, operator, licensor, licensee, lender, partner,
      stockholder, joint venturer, employee, consultant, advisor or otherwise)
      competitive with the business activities conducted by the Company, its
      subsidiaries, or affiliates during the Term which business activities include
      the CAD (computer aided detection) of breast cancer and colon cancer or any
      other areas the Company may operate or business activities the Company may
      engage in.. Notwithstanding the foregoing, nothing herein shall prevent the
      Executive from owning stock in a publicly traded corporation whose activities
      compete with those of the Company’s, provided that such stock holdings are not
      greater than two percent (2%) of the outstanding stock of such corporation.
      

     

    7.4. The
      Executive shall not, during the Term and for a period of two years after the
      Date of Termination, directly or indirectly, take any action which constitutes
      an interference with or a disruption of any of the Company’s business activities
      including, without limitation, the solicitations of the Company’s customers,
      distributors or vendors or persons listed on the personnel lists of the Company.
      

     

    7.5. For
      purposes of clarification, but not of limitation, the Executive hereby
      acknowledges and agrees that the provisions of Sections 7.3 and 7.4 above shall
      serve as a prohibition against her from, during the period referred to therein,
      directly or indirectly, hiring, offering to hire, enticing, soliciting or in
      any
      other manner persuading or attempting to persuade any officer, employee, agent,
      lessor, lessee, licensor, licensee or customer of the Company (but only those
      suppliers existing during the time of the Executive’s employment by the Company,
      or at the termination of her employment), to discontinue or alter her, her
      or
      its relationship with the Company.

     

    7.6. (a) The
      Executive agrees that all processes, technologies and inventions (“Inventions”),
      including new contributions, improvements, ideas and discoveries, whether
      patentable or not, conceived, developed, invented or made by her during the
      Term
      shall belong to the Company, provided that such Inventions grew out of the
      Executive’s work with the Company, are related in any manner to the business
      (commercial or experimental) of the Company or are conceived or made on the
      Company’s time or with the use of the Company’s facilities or materials. The
      Executive shall further: (a) promptly disclose such Inventions to the Company;
      (b) assign to the Company, without additional compensation, all patent and
      other
      rights to such Inventions for the United States and foreign countries; (c)
      sign
      all papers necessary to carry out the foregoing; and (d) give testimony in
      support of her inventorship;

     

    (b) If
      any
      Invention is described in a patent application or is disclosed to third parties,
      directly or indirectly, by the Executive within two (2) years after the
      termination of her employment by the Company, it is to be presumed that the
      Invention was conceived or made during the Term by the Company; and

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    

     

    (c) The
      Executive agrees that she will not assert any rights to any Invention as having
      been made or acquired by her prior to the date of this Agreement, except for
      Inventions, if any, disclosed to the Company in writing prior to the date
      hereof.

     

    7.7. The
      Company shall be the sole owner of all products and proceeds of the Executive’s
      services hereunder, including, but not limited to, all materials, ideas,
      concepts, formats, suggestions, developments, arrangements, packages, programs
      and other intellectual properties that the Executive may acquire, obtain,
      develop or create in connection with and during the term of the Executive’s
      employment hereunder, free and clear of any claims by the Executive (or anyone
      claiming under the Executive) of any kind or character whatsoever (other than
      the Executive’s right to receive payments hereunder). The Executive shall, at
      the request of the Company, executive such assignments, certificates or other
      instruments as the Company may from time to time deem necessary or desirable
      to
      evidence, establish, maintain, perfect, protect, enforce or defend its right,
      or
      title and interest in or to any such properties.

     

    7.8. At
      no
      time during or after the Term shall the Executive, directly or indirectly,
      disparage the commercial, business, professional or financial, as the case
      may
      be, reputation of the Company or its officers or directors.

     

    7.9. Without
      intending to limit the remedies available to the Company, the Executive
      acknowledges that a breach of any of the covenants contained in this Section
      7
      may result in material and irreparable injury to the Company, or its affiliates
      or subsidiaries, for which there is no adequate remedy at law, that it will
      not
      be possible to measure damages for such injuries precisely and that, in the
      event of such a breach or threat the Company shall be entitled to seek a
      temporary restraining order and/or a preliminary or permanent injunction
      restraining the Executive from engaging in activities prohibited by this Section
      7 or such other relief as may be required specifically to enforce any of the
      covenants in this Section 7. The Executive hereby acknowledges and agrees that
      the type and periods of restrictions imposed in this Section 7 are fair and
      reasonable and are reasonably required for the protection of the Company’s
      confidential information and the goodwill associated with the business of the
      Company. Further, the Executive acknowledges and agrees that the restrictions
      imposed in this Section 7 will not prevent her from obtaining suitable
      employment after her employment with the Executive ceases or from earning a
      livelihood. If for any reason it is held that the restrictions under this
      Section 7 are not reasonable or that consideration therefor is inadequate,
      such
      restrictions shall be interpreted or modified to include as much of the duration
      and scope identified in this Section as will render such restrictions valid
      and
      enforceable.

     

    8. EXECUTIVE’S
      COOPERATION

     

    During
      the Term and thereafter, the Executive shall cooperate with the Company in
      any
      internal investigation or administrative, regulatory or judicial proceeding
      as
      reasonably requested by the Company (including, without limitation, the
      Executive being available to the Company upon reasonable notice for interviews
      and factual investigations, appearing at the Company’s request to give testimony
      without requiring service of a subpoena or other legal process, volunteering
      to
      the Company all pertinent information and turning over to the Company all
      relevant documents which are or may come into the Executive’s possession, all at
      times and on schedules that are reasonably consistent with the Executive’s other
      permitted activities and commitments). In the event the Company requires the
      Executive’s cooperation in accordance with this section after the termination of
      the Term, the Company shall reimburse the Executive for all of her reasonable
      costs and expenses incurred, in connection therewith, plus pay the Executive
      a
      reasonable amount per day for her time spent.

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

    

     

    9. RIGHTS
      OF
      INDEMNIFICATION

     

    The
      Company shall indemnify the Executive to the fullest extent permitted by the
      General Corporation Law of the State of Delaware, as amended from time to time,
      for all amounts (including without limitation, judgments, fines, settlement
      payments, expenses and attorney’s fees) incurred or paid by the Executive in
      connection with any action, suit, investigation or proceeding arising out of
      or
      relating to the performance by the Executive of services for, or the acting
      by
      the Executive as a director, officer or employee of the Company, or any other
      person or enterprise at the Company’s request.

     

    10. MISCELLANEOUS

     

    10.1. Notices.
      All
      notices or communications hereunder shall be in writing, addressed as
      follows:

     

    
      	 	
              To
                the Company:

            	
              iCAD,
                Inc.

              4
                Townsend West, Suite 17

              Nashua,
                New Hampshire 03063

              Attn:
                Chief Executive Officer

            
	 	 	 
	 	 	
              with
                a copy to: 

            
	 	 	 
	 	 	
              Blank
                Rome LLP

              405
                Lexington Avenue

              New
                York, NY 10174

              Attn:
                Robert J. Mittman, Esq.

            
	 	 	 
	 	
              To
                the Executive:

            	
              Darlene
                M. Deptula-Hicks

            
	 	 	
              30
                Crane Crossing Road

            
	 	 	
              Plaistow,
                NH 03865

            
	 	 	 

    

    

    All
      such
      notices shall be conclusively deemed to be received and shall be effective
      (i) if sent by hand delivery, upon receipt, (ii) if sent by telecopy
      or facsimile transmission, upon confirmation of receipt by the sender of such
      transmission, (iii) if sent by overnight courier, one business day after
      being sent by overnight courier, or (iv) if sent by registered or certified
      mail, postage prepaid, return receipt requested, on the fifth day after the
      day
      on which such notice is mailed.

     

    10.2. Severability.
      Each
      provision of this Agreement shall be interpreted in such manner as to be
      effective and valid under applicable law, but if any provision of this Agreement
      is held to be prohibited by or invalid under applicable law, such provision
      will
      be ineffective to the extent of such prohibition or invalidity, without
      invalidating the remainder of such provision or the remaining provisions of
      this
      Agreement.

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

    

     

    10.3. Binding
      Effect; Benefits.
      Executive may not delegate her duties or assign her rights hereunder. This
      Agreement shall inure to the benefit of, and be binding upon, the parties hereto
      and their respective heirs, legal representatives, successors and permitted
      assigns.

     

    10.4. Entire
      Agreement.
      This
      Agreement represents the entire agreement of the parties and shall supersede
      any
      and all previous contracts, arrangements or understandings between the Company
      and the Executive. This Agreement may be amended at any time by mutual written
      agreement of the parties hereto. In the case of any conflict between any express
      term of this Agreement and any statement contained in any employment manual,
      memo or rule of general applicability of the Company, this Agreement shall
      control.

     

    10.5. Warranty.
      The
      Executive hereby represents and warrants as follows: (i) that the execution
      of this Agreement and the discharge of the Executive’s obligations hereunder
      will not breach or conflict with any other contract, agreement, or understanding
      between the Executive and any other party or parties; and (ii) the
      Executive’s resume which was provided to the Company by the Executive and other
      statements made about the Executive’s employment history to the Company by the
      Executive are true, accurate and complete in all material respects.

     

    10.6. Withholding.
      The
      payment of any amount pursuant to this Agreement shall be subject to applicable
      withholding and payroll taxes, and such other deductions as may be required
      under the Company’s employee benefit plans, if any.

     

    10.7. Governing
      Law.
      This
      Agreement and the performance of the parties hereunder shall be governed by
      the
      internal laws (and not the law of conflicts) of the State of Delaware. Any
      claim
      or controversy arising out of or in connection with this Agreement, or the
      breach thereof, shall be adjudicated exclusively by the state courts for the
      State of New Hampshire, or by a federal court sitting in New Hampshire. The
      parties hereto agree to the personal jurisdiction of such courts and agree
      to
      accept process by regular mail in connection with any such dispute.

     

    10.8. Execution
      in Counterparts.
      This
      Agreement may be executed by the parties in one or more counterparts, each
      of
      which shall be deemed to be an original but all of which taken together shall
      constitute one and the same agreement, and shall become effective when one
      or
      more counterparts has been signed by each of the parties hereto and delivered
      to
      each of the other parties hereto. A photocopy or electronic facsimile of this
      Agreement or of any signature hereon shall be deemed an original for all
      purposes.

     

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

    

     

    IN
      WITNESS WHEREOF, the Company has caused this Agreement to be duly executed
      and
      the Executive has hereunto set her hand, as of the day and year first above
      written,

     

    
      	 	THE
              COMPANY:
	 	 	 
	 	iCAD,
              INC
	 	 	 
	 	 	 
	 	 	
               

            
	 	
              By:

            	
              /s/
                Kenneth Ferry

            
	 	 	
              Name:

            
	 	 	
              Title:
                CEO

            
	 	 	 
	 	EXECUTIVE
	 	 	 
	 	 /s/
              Darlene M. Deptula-Hicks 
	 	 Darlene
              M. Deptula-Hicks

    

    

    
      
        
        

      

      
        13Unassociated Document

    THIS
      OPTION AND THE SHARES ISSUABLE UPON EXERCISE OF THIS OPTION HAVE NOT BEEN
      REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) IN
      RELIANCE UPON THE EXEMPTIONS CONTAINED IN THE ACT. THIS OPTION AND ANY SHARES
      ISSUED UPON EXERCISE OF THIS OPTION MAY NOT BE OFFERED FOR SALE, SOLD,
      TRANSFERRED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS (i) REGISTERED
      UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS; (ii) PURSUANT TO RULE
      144 UNDER SUCH ACT (OR ANY SIMILAR RULE UNDER SUCH ACT RELATING TO THE
      DISPOSITION OF SECURITIES); OR (iii) THE CORPORATION HAS RECEIVED AN
      OPINION OF COUNSEL ACCEPTABLE TO THE CORPORATION THAT SUCH REGISTRATION IS
      NOT
      REQUIRED.

    

    ICAD,
      INC. 

    

    Option

    

    

    275,000
      Shares 

    of
      Common
      Stock

    

    THIS
      CERTIFIES that, for value received, Darlene M. Deptula-Hicks or her permitted
      assigns (the “Grantee”), is entitled to subscribe for and purchase from ICAD,
      INC., a Delaware corporation (the “Corporation”), on the terms and conditions
      set forth herein, 275,000 shares of fully paid and nonassessable common stock,
      $.001 par value per share (“Common Stock”), of the Corporation. This Option and
      any Option or Options subsequently issued upon exchange hereof are hereinafter
      collectively referred to as this “Option.”

     

    Section
      1. Exercise
      of Option.

     

    1.1. Exercise
      Price; Term.

     

    (a) The
      price
      of the shares of Common Stock purchasable pursuant to this Option shall be
      $ per
      share, subject to adjustment pursuant to Section 3 below (such price, as
      adjusted from time to time, being hereinafter referred to as the “Exercise
      Price”). This Option shall become exercisable as to (i) 55,000 Shares (the
“Shares”) immediately, (ii) an additional 55,000 Shares on March 31, 2007;
      (iii) an additional 55,000 Shares on September 11, 2007, (ii) an additional
      55,000 Shares on September 11, 2008; and (iii) an additional 55,000 Shares
      on September 11, 2009. This Option shall expire at 5:00 p.m., New York time,
      on
      September 11, 2011 (the “Expiration Date”), subject to earlier expiration as set
      forth below. Vesting of this Option shall accelerate as to the 55,000 Shares
      to
      which this Option becomes exercisable at the latest date (to the extent this
      Option remain unvested with respect to any such Shares at the time), upon the
      closing sale price of the Corporation’s common stock for a period of
      twenty (20) consecutive trading days exceeding (i) 200% of the
      exercise price of the per share of this Option; (ii) 300% of the exercise
      price per share of this Option or (iv) 400% of the exercise price per share
      of
      this Option.

     

    
      
         

      

      
        
        

        
          

        

      

      
         

      

    

    

     

    (b) If
      the
      Grantee ceases to be employed by the Corporation for any reason other than
      death, termination for cause, or voluntary termination without the written
      consent of the Corporation, the Option may be exercised within ninety (90)
      days (or, if applicable, such later date specified in the employment agreement
      between the Grantee and the Corporation where Grantee’s employment is terminated
      without cause or for good reason following a change of control of the
      Corporation as defined in such employment agreement) of such termination after
      the date the Grantee ceases to be an employee, or within five (5) years
      from the granting of the Option, whichever is earlier, but may not be exercised
      thereafter. In such event, the Option shall be exercisable only to the extent
      that the right to purchase Shares under the Plan has accrued and is in effect
      at
      the date of such cessation of employment.

     

    (c) In
      the
      event of disability of the Grantee (as determined by the Board of Directors
      of
      the Corporation in accordance with the Employment Agreement dated September
      8 ,
      2006, by and between the Corporation and Grantee, and as to the fact and date
      of
      which the Grantee is notified by the Board), the Option shall be exercisable
      within ninety (90) days after the date of such disability or, if earlier,
      the term originally prescribed by this Agreement. In such event, the Option
      shall be exercisable to the extent that the right to purchase the Shares
      hereunder has accrued on the date the Grantee becomes disabled and is in effect
      as of such determination date.

     

    (d) In
      the
      event of the death of the Grantee while an employee of the Corporation, the
      Option shall be exercisable to the extent exercisable but not exercised as
      of
      the date of death and in such event, the Option must be exercised, if at all,
      within ninety (90) days after the date of death of the Grantee or, if
      earlier, within the originally prescribed term of the Option.

     

     

    1.2. Exercise.
      This
      Option may be exercised in whole or in part (to the extent that it is
      exercisable in accordance with its terms) by giving written notice to the
      Corporation at its principal executive office, together with the tender, by
      cash
      or check, of the Exercise Price of the Shares covered by this Option. Such
      written notice shall be signed by the person exercising this Option, shall
      state
      the number of Shares with respect to which this Option is being exercised,
      shall
      contain any warranty required by Section 7 below and shall otherwise comply
      with the terms and conditions of this Option. The Corporation shall pay all
      original issue taxes with respect to the issue of the shares of Common Stock
      pursuant hereto and all other fees and expenses necessarily incurred by the
      Corporation in connection herewith. Except as specifically set forth herein,
      the
      Grantee acknowledges that any income or other taxes due from her with respect
      to
      this Option or the Shares issuable pursuant to this Option shall be the
      responsibility of the Grantee.

     

     

    1.3. Issuance
      of Securities.
      Upon
      the exercise of this Option, a certificate or certificates for the Shares so
      purchased, registered in the name of the Grantee, shall be delivered to the
      Grantee and, unless this Option has expired, a new Option representing the
      number of Shares (except a remaining fractional share), if any, with respect
      to
      which this Option shall not then have been exercised shall also be issued to
      the
      Grantee within such time. The Grantee shall for all purposes be deemed to have
      become the Grantee of record of the Shares issued upon exercise of this Option
      on the date on which the Option was surrendered and payment of the Exercise
      Price and any applicable taxes was made, except that, if the date of such
      surrender and payment is a date on which the stock transfer books of the
      Corporation are closed, the Grantee shall be deemed to have become the Grantee
      of such shares at the close of business on the next succeeding date on which
      the
      stock transfer books are open.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    

     

    Section
      2. Adjustment
      of Number of Shares Subject to Option.
      Upon
      any adjustment of the Exercise Price pursuant to Section 3 hereof, the
      Grantee shall thereafter be entitled to purchase, at the adjusted Exercise
      Price, the number of shares (calculated to the nearest tenth of a share)
      obtained by multiplying the Exercise Price in effect immediately prior to such
      adjustment by the number of shares purchasable pursuant hereto immediately
      prior
      to such adjustment and dividing the product thereof by the Exercise Price
      resulting from such adjustment.

     

    Section
      3. Adjustment
      of Exercise Price.

     

    (a) If
      the
      Corporation shall split, subdivide or combine its Common Stock, the Exercise
      Price shall be proportionately decreased in the case of a split or subdivision
      or increased in the case of a combination.

     

    (b) If
      the
      Corporation shall pay a dividend with respect to the Common Stock or make any
      other distribution with respect to the Common Stock, except any distribution
      specifically provided for in Section 4 below, payable in Shares, then the
      Exercise Price shall be adjusted, from and after the date of determination
      of
      the stockholders entitled to receive such dividend or distribution, to that
      price determined by multiplying the Exercise Price in effect immediately prior
      to such date of determination by a fraction (i) the numerator of which
      shall be the total number of shares of Common Stock outstanding immediately
      prior to such dividend or distribution, and (ii) the denominator of which
      shall be the total number of shares of Common Stock outstanding immediately
      after such dividend or distribution.

     

    Section
      4. Reclassification,
      Merger, etc.
      In the
      case of any reclassification of the Common Stock or in the case of any
      consolidation or merger of the Corporation with or into another corporation
      (other than a merger with another corporation in which the Corporation is the
      surviving corporation and which does not result in any reclassification of
      the
      Common Stock) or in the case of any sale of all or substantially all of the
      assets of the Corporation, then the Corporation, or such successor or purchasing
      corporation, as the case may be, shall execute a new Option, providing that
      the
      Grantee shall have the right to exercise such new Option and upon such exercise
      to receive, in lieu of each share of Common Stock theretofore issuable upon
      exercise of this Option, the number and kind of shares of stock, other
      securities, money or property receivable upon such reclassification, change,
      consolidation or merger by a Grantee of shares of the Common Stock with respect
      to one share of Common Stock. Such new Option shall provide for adjustments
      which shall be identical to the adjustments provided for herein. The provisions
      of this Section 4 shall similarly apply to successive reclassifications,
      changes, consolidations or mergers.

     

    Section
      5. Stock
      to Be Reserved.
      The
      Corporation will at all times reserve and keep available out of its authorized
      Common Stock or its treasury shares, solely for the purpose of issue upon the
      exercise of this Option as herein provided, such number of shares of Common
      Stock as shall then be issuable upon the exercise of this Option. The
      Corporation covenants that all shares of Common Stock which shall be so issued
      shall be duly and validly issued and fully paid and nonassessable and free
      from
      all taxes, liens and charges with respect to the issue thereof

     

    Section
      6. No
      Stockholder Rights or Liabilities.
      This
      Option shall not entitle the Grantee to any voting rights or other rights as
      a
      stockholder of the Corporation. No provision hereof, in the absence of
      affirmative action by the Grantee to purchase shares of Common Stock, and no
      mere enumeration herein of the rights or privileges of the Grantee, shall give
      rise to any liability of the Grantee for the Exercise Price or as a stockholder
      of the Corporation, whether such liability is asserted by the Corporation or
      by
      creditors of the Corporation. The Grantee of this Option shall have rights
      as a
      stockholder of the Corporation only with respect to any shares of Common Stock
      covered by the Option after due exercise of the Option and tender of the full
      purchase price for the shares of Common Stock being purchased pursuant to such
      exercise.

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    

     

    Section
      7. Investment
      Representation and Legend.
      The
      Grantee, by acceptance of this Option, represents and warrants to the
      Corporation that the Grantee is receiving the Option and, unless at the time
      of
      exercise a registration statement under the Securities Act of 1933, as amended
      (the “Act”), is effective with respect to such shares, upon the exercise hereof
      will acquire the shares of Common Stock issuable upon such exercise, for
      investment purposes only and not with a view towards the resale or other
      distribution thereof except pursuant to an effective registration statement
      under the Act or an applicable exemption from registration under the Act. The
      Grantee also hereby agrees that the Grantee shall not sell, transfer by any
      means or otherwise dispose of the Option or the shares of Common Stock issuable
      upon exercise of the Option without registration under the Act unless in the
      opinion of counsel reasonably acceptable to the Corporation such proposed sale
      or transfer is exempt from the registration provisions of the Act.

     

    The
      Grantee, by acceptance of this Option, agrees that the Corporation may affix,
      unless the shares subject to this Option are registered at the time of exercise,
      a legend to the certificates for shares of Common Stock issued upon exercise
      of
      this Option in substantially the following form:

     

    THE
      SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THE SHARES MAY NOT BE OFFERED
      FOR SALE, SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS
      (i) REGISTERED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS;
      (ii) PURSUANT TO RULE 144 UNDER SUCH ACT (OR ANY SIMILAR RULE UNDER SUCH
      ACT RELATING TO THE DISPOSITION OF SECURITIES); OR (iii) THE CORPORATION
      HAS RECEIVED AN OPINION OF COUNSEL ACCEPTABLE TO THE CORPORATION THAT SUCH
      REGISTRATION IS NOT REQUIRED.

     

    

     

    Section
      8. Lost,
      Stolen, Mutilated or Destroyed Option.
      If this
      Option is lost, stolen, mutilated or destroyed, the Corporation may, on such
      terms as to indemnity or otherwise as it may in its discretion reasonably impose
      (which shall, in the case of a mutilated Option, include the surrender thereof),
      issue a new Option of like denomination and tenor as the Option so lost, stolen,
      mutilated or destroyed.

     

    Section
      9. Successors.
      All the
      covenants and provisions of this Agreement shall be binding upon and inure
      to
      the benefit of the Corporation, the Grantee and their respective successors
      and
      assigns hereunder.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    

     

    Section
      10. Governing
      Law.
      This
      Option shall be deemed to be a contract made under the laws of the State of
      Delaware and for all purposes shall be construed in accordance with the laws
      of
      the said State without giving effect to the rules of said State governing the
      conflicts of law.

     

    Section
      11. Transferability.
      This
      Option shall not be transferable by the Grantee other than by will or the laws
      of descent and distribution and shall be written during the Grantee’s lifetime,
      only by the Grantee, without the written consent of the Corporation to the
      transfer.

     

    Section
      12. Notices.
      All
      notices, requests, consents and other communications hereunder shall be in
      writing and shall be deemed to have been duly made when delivered, or mailed
      by
      registered or certified mail, return receipt requested:

     

    (a) If
      the
      Grantee of this Option, to the address of the Grantee; or

     

    (b) If
      to the
      Corporation, to the address of the Corporation’s principal executive office as
      disclosed in the periodic filings made by the Corporation with the United States
      Securities and Exchange Commission or such other address as the Corporation
      may
      designate by notice to the Grantee.

     

    IN
      WITNESS WHEREOF, the Corporation has executed this Option by its authorized
      signatory.

     

    

    
      	 	ICAD,
              INC.
	
              Dated:
                September 8, 2006

            	 	
               

            
	 	 	 
	 	
              By:
                

            	
              /s/
                Kenneth Ferry

            
	 	 	
              Name:

            
	 	 	
              Title:
                CEO

            

    

    

    

    

    
      
         

      

      
        5

        
          

        

      

      
         

        
        

      

    

    

    [FORM
      OF ELECTION TO PURCHASE]

    

    

    The
      undersigned hereby irrevocably elects to exercise the right, represented by
      this
      Option, to purchase ______ shares of the Common Stock of ICAD, INC. or any
      successor corporation (the “Corporation”) and herewith tenders, in payment
      for such shares, cash or a check payable to the order of
      __________________________________, in the amount of $_________________, or
      by
      delivery to the Corporation of a Notice of Exchange, all in accordance with
      the
      terms hereof. The undersigned requests that a certificate for such shares be
      registered in the name of ______________________ whose address is
      __________________________, and that such certificate be delivered to
      _________________, whose address is ____________________________.

    

    

    
      	
              Dated:

            	
              Signature:___________________

            
	 	 
	 	
              (Signature
                must conform in all respects to name of Grantee as specified on the
                face
                of the Option Certificate.)

            

    

    

    

    _______________________________

    

    _______________________________

    (Insert
      Social Security or other

    Identifying
      number of Grantee)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}]]